Filing Flows › Iradimed (IRMD) › Q3 2025
Iradimed (IRMD) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 3, 2025
Iradimed (IRMD) reported revenue of $21.2M for the third quarter 2025 (Q3 2025), +16% from a year earlier and +4% from the quarter before. Operating margin was 32.2%, net earnings $5.6M (26.3% of revenue).
Iradimed, Q3 2025: revenue $21.2M (+16% year over year), operating margin 32.2%, net earnings $5.6M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.2M | +4% | +16% |
| Gross profit | $16.5M | +3% | +16% |
| Operating profit | $6.8M | +0.7% | +18% |
| Net earnings | $5.6M | -3% | +10% |
| Operating cash flow | $7.0M | -10% | -23% |
| Free cash flow | $5.7M | — | +12% |
What changed
Revenue was $21.2M in Q3 2025, up 16% year over year and up 4% from the previous quarter.
Gross margin was 77.8%, up 0.4 points from a year earlier. Operating profit was $6.8M, a 32.2% margin (up 0.6 points year over year). Of the extra revenue versus a year earlier, 36% reached operating profit, above the 32% margin then. Operating expenses grew 15% against revenue growth of 16%. The fastest-growing cost line was Sales & marketing (+22%). Net earnings were $5.6M, up 10% year over year. The effective tax rate was 23.6%.
Operating cash flow was $7.0M (down 23% year over year), 125% of net earnings. Non-cash charges added back $383K of depreciation and amortization and $666K of share-based compensation. Working capital and other items added $360K. After capital Expenditures ($1.3M), free cash flow as the company reports it was $5.7M.
Questions
What was Iradimed's revenue in the third quarter 2025?
Iradimed (IRMD) reported revenue of $21.2M for the third quarter 2025 (Q3 2025), +16% from a year earlier and +4% from the quarter before.
Was Iradimed profitable in the third quarter 2025?
Operating profit was $6.8M (32.2% of revenue) and net earnings $5.6M.
Source: Iradimed 10-Q on SEC EDGAR.